BIRC3 and ovarian cancer: The result showed that the positive expression rate of BIRC3 in ovarian cancer tissue (92.96%, 66/71 cases) was higher than that in normal interstitial tissue (26.7%, 4/15 cases) (Fig. 6a), indicating that BIRC3 was overexpressed in ovarian cancer tissue.